Overview

A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
A 6-week in-patient and out-patient study to test the effectiveness and safety of a new medication in the treatment of schizophrenia
Phase:
Phase 2
Details
Lead Sponsor:
Sunovion
Treatments:
Lurasidone Hydrochloride